Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacodynamics of the antiarrhythmic disopyramide in healthy humans: correlation of the kinetics of the drug and its effects.

Literature DB >> 978390

Pharmacodynamics of the antiarrhythmic disopyramide in healthy humans: correlation of the kinetics of the drug and its effects.

P H Hinderling, E R Garrett.

Abstract

Entities: Chemical Species

Mesh：

Substances：
Pyridines
Disopyramide

Year: 1976 PMID： 978390 DOI： 10.1007/BF01063615

Source DB: PubMed Journal: J Pharmacokinet Biopharm ISSN： 0090-466X

× No keyword cloud information.

17 in total

1. Pharmacology of a new antiarrhythmic agent, gamma-diisopropyl-amino-alpha-phenyl-alpha-(2-pyridyl)-butyramide (SC-7031).

Authors: C M MOKLER; C G VAN ARMAN
Journal: J Pharmacol Exp Ther Date: 1962-04 Impact factor: 4.030

2. Pharmacokinetics of the antiarrhythmic disopyramide in healthy humans.

Authors: P H Hinderling; E R Garrett
Journal: J Pharmacokinet Biopharm Date: 1976-06

3. Disopyramide in the prevention of recurrence of atrial fibrillation after electroconversion.

Authors: G Härtel; A Louhija; A Konttinen
Journal: Clin Pharmacol Ther Date: 1974-06 Impact factor: 6.875

4. Disopyramide phosphate: clinical efficacy of a new oral antiarrhythmic drug.

Authors: L A Vismara; D T Mason; E A Amsterdam
Journal: Clin Pharmacol Ther Date: 1974-08 Impact factor: 6.875

5. Effects of disopyramide on electrophysiological and mechanical properties of the heart.

Authors: B K Yeh; P K Sung; B J Scherlag
Journal: J Pharm Sci Date: 1973-12 Impact factor: 3.534

6. Effects of disopyramide on the A-V conduction system.

Authors: R R Dean; D M Ferguson
Journal: Arch Int Pharmacodyn Ther Date: 1971-03

7. [A new antiarrhythmic agent: disopyramide].

Authors: J Granier
Journal: Presse Med Date: 1968-09-07 Impact factor: 1.228

8. Haemodynamic effects of intravenous disopyramide in heart failure.

Authors: G Jensen; B Sigurd; A Uhrenholt
Journal: Eur J Clin Pharmacol Date: 1975-04-04 Impact factor: 2.953

9. Electrophysiologic effects of the antiarrhythmic agent disopyramide phosphate.

Authors: B Befeler; A Castellanos; D E Wells; M C Vagueiro; B K Yeh
Journal: Am J Cardiol Date: 1975-02 Impact factor: 2.778

10. A COMPARISON OF THE ANTIFIBRILLATORY ACTIONS AND EFFECTS ON INTRACELLULAR CARDIAC POTENTIALS OF PRONETHALOL, DISOPYRAMIDE AND QUINIDINE.

Authors: A SEKIYA; E M VAUGHANWILLIAMS
Journal: Br J Pharmacol Chemother Date: 1963-12

11 in total

Review 1. Therapeutic drug monitoring of antiarrhythmic drugs.

Authors: Gesche Jürgens; Niels A Graudal; Jens P Kampmann
Journal: Clin Pharmacokinet Date: 2003 Impact factor: 6.447

2. Pharmacokinetics of disopyramide in patients with chronic renal failure.

Authors: B Francois; R Mallein; J Rondelet; M Lussignol
Journal: Eur J Drug Metab Pharmacokinet Date: 1983 Impact factor: 2.441

Review 3. Therapeutic drug monitoring of antiarrhythmic agents.

Authors: J E Brown; D G Shand
Journal: Clin Pharmacokinet Date: 1982 Mar-Apr Impact factor: 6.447

4. Quantitative analysis of the disopyramide concentration-effect relationship.

Authors: B Whiting; N H Holford; L B Sheiner
Journal: Br J Clin Pharmacol Date: 1980-01 Impact factor: 4.335

5. Pharmacokinetics and pharmacodynamics of the antiarrhythmic compound MD750819 in dogs with experimentally induced arrhythmias.

Authors: J Dow; B Laquais; J Tisne-Versailles; B Pourrias; M S Benedetti
Journal: J Pharmacokinet Biopharm Date: 1982-06

9. [The effect of disopyramide of left ventricular function: an echocardiographic study of the extent and time course (author's transl)].

Authors: C Angermann; G Autenrieth
Journal: Klin Wochenschr Date: 1981-07-15

Review 10. Disopyramide. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiac arrhythmias.

Authors: R N Brogden; P A Todd
Journal: Drugs Date: 1987-08 Impact factor: 9.546